+91 8208210706   Ozarcare0706@gmail.com

In Stock

Dilzem 30 Tablet CR

Dilzem 30 Tablet CR is a controlled-release calcium channel blocker containing Diltiazem, used to manage high blood pressure, angina, and certain heart rhythm disorders. It relaxes blood vessels, improves blood flow, reduces heart workload, and helps maintain stable heart rhythm.

Original price was: ₹1.50.Current price is: ₹1.00.

Category:

Description

Key Benefits:

  • Helps lower high blood pressure (hypertension).

  • Improves heart function in certain heart conditions.

  • Reduces the risk of angina-related complications, stroke, and heart attack.

  • Supports overall cardiovascular health.

  • Aids in better blood circulation and stabilizes heart rhythm.

Composition / Specifications:

  • Active Ingredient: Diltiazem Hydrochloride – 30 mg (Controlled Release)

  • Tablet form for oral administration

Recommended Usage:

  • Take as directed by your physician.

  • Usually once daily, with or without food.

  • Swallow the tablet whole with water; do not crush, chew, or break the CR tablet.

Safety Information:

  • Avoid if you have severe heart block, low blood pressure, or known hypersensitivity to diltiazem.

  • Consult your doctor if you experience dizziness, swelling, slow heart rate, or persistent fatigue.

  • Not recommended during pregnancy or breastfeeding without medical advice.

  • Inform your doctor about other medications to avoid interactions.

Possible Side Effects / Considerations:

  • Dizziness or lightheadedness

  • Swelling (edema)

  • Fatigue

  • Headache or flushing

  • Rarely, slow heart rate or liver enzyme changes

Storage:

  • Store below 30Β°C in a cool, dry place.

  • Keep away from direct sunlight and moisture.

  • Keep out of reach of children.

Disclaimer:
Use Dilzem 30 Tablet CR under medical supervision only. Do not adjust dosage or stop treatment without consulting your doctor

Reviews

There are no reviews yet.

Be the first to review “Dilzem 30 Tablet CR”

Your email address will not be published. Required fields are marked *